Kaletra (Lopinavir 200mg/Ritonavir 50mg)

Kaletra (Lopinavir 200mg / Ritonavir 50mg) – Patient Information Leaflet

Basic Product Information

Mechanism of Action

For Patients: Kaletra is a combination medication containing two antiretroviral medicines: lopinavir and ritonavir. Both belong to a group of medicines called 'protease inhibitors.' These work by blocking an important enzyme (the HIV protease) that the HIV virus needs to multiply in your body. Without this enzyme, the virus cannot complete its life cycle and is less able to infect new cells.

For Healthcare Professionals: Lopinavir is the main active protease inhibitor, while ritonavir is included primarily as a pharmacokinetic enhancer. Ritonavir inhibits CYP3A-mediated metabolism of lopinavir, increasing plasma concentration and exposure to lopinavir, ensuring sustained viral suppression.

Pharmacokinetics

• Absorption: Oral bioavailability is improved when taken with food. Peak plasma levels are usually reached within 4 hours.
• Metabolism: Extensively metabolised in the liver (CYP3A4-mediated). Ritonavir strongly inhibits CYP3A enzymes.
• Elimination: Most active substances are excreted via the stool; less than 2% is renally excreted.
• Duration of Action: Terminal half-life is around 5 to 6 hours when administered in combination.

Use in Everyday Life and Best Practices

Kaletra is prescribed as part of combination antiretroviral therapy (ART) for people living with HIV-1. In Australia, it is usually prescribed by an infectious diseases specialist or a specially trained GP. It’s essential to take Kaletra exactly as prescribed to help control your HIV infection and reduce the risk of resistance.

• Standard Adult Dose: Two tablets (Lopinavir 400mg/Ritonavir 100mg) taken twice daily, or four tablets once daily (see below for more detail).
• Tablets should be swallowed whole with water.
• Do not skip doses or stop suddenly unless instructed by your doctor.
• Antiretroviral therapy is lifelong; consistent use is key to success.

For best results, take the medication at the same time each day to maintain steady drug levels in your blood.

Dosing: Morning vs Evening (Timing Matters)

• Morning dosing: Can help avoid insomnia or vivid dreams sometimes caused by ART.
• Evening dosing: May suit those with gastrointestinal side effects, as sleep may lessen symptoms like nausea.
• Choose the time that fits best with your routine; consistency is more important than time of day. Setting reminders is advised.

Taking With Food or on an Empty Stomach

Kaletra tablets may be taken with or without food, though food enhances absorption and may reduce stomach upset, a common side effect:

• Best practice: Take with a meal or snack, consistent with the typical Australian diet.
• Oral solution: Should be taken with food due to taste and absorption issues.
• Foods to avoid: High-fat meals can increase drug levels but do not typically cause harm; follow your normal diet unless your doctor tells you otherwise.
• Alcohol: Should be limited, especially with the oral solution which contains alcohol.

Interaction Warnings

Kaletra has numerous potential interactions. Always inform your doctor or pharmacist of all medicines, supplements, and herbal products you use.

Indications

Dosing According to Clinical Indication

Safety Profile and Side Effects

• Common: Nausea, diarrhoea, abdominal pain, tiredness, raised cholesterol or triglycerides, altered taste, headache.
• Occasional: Liver enzyme increases, skin rash, sleep disturbance, muscle aches.
• Rare but serious: Severe liver or pancreas inflammation, allergic reactions, heart rhythm problems, lactic acidosis.

Contact your doctor immediately if you notice yellowing of the eyes or skin, severe abdominal pain, unexplained muscle pain, or irregular heartbeat.

Guidelines for Proper Use

• Take Kaletra exactly as prescribed; do not stop without advice from your HIV team.
• Keep all medical and pharmacy appointments for regular blood tests and monitoring.
• Store below 25°C, away from moisture, and out of reach of children.
• Order refills early, especially ahead of weekends or public holidays.
• If you forget a dose and it’s within 6 hours, take it; if more than 6 hours, skip and resume next dose. Do not double up.
• If you vomit within 1 hour of taking a tablet, take another dose. If more than 1 hour, wait for the next scheduled dose.
• Kaletra does not prevent you from spreading HIV to others; continue safe-sex and safe needle practices.

Alternative Treatment Options

Australia’s Pharmaceutical Benefits Scheme (PBS) lists several alternative combination antiretrovirals, many reimbursed for eligible patients:

• Dolutegravir-based regimens (e.g., Tivicay + Truvada)
• Darunavir/cobicistat (Prezcobix)
• Efavirenz-based combinations
• Bictegravir/emtricitabine/tenofovir (Biktarvy)
• Atazanavir + ritonavir plus backbone

Pros: Newer regimens are often better tolerated, cause fewer drug interactions, and require only once-daily dosing.
Cons: Kaletra remains useful when resistance to other drugs exists, during pregnancy, and when complex comorbidities are present.

Legal, Registration, and Reimbursement Status in Australia

• Kaletra is a registered prescription medicine (ARTG No. 83248; TGA approved).
• Listed on the PBS for treatment of HIV when prescribed by a specialist or trained GP.
• Not available over the counter; repeat scripts required for ongoing supply.
• Comprehensive HIV care is supported by state and federal programs across Australia.

Latest Research and Clinical Guidance (2022–2025)

• HIV: Recent ASHM (Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine) and International Antiviral Society–USA guidelines recommend integrase inhibitor-based regimens as first line; Kaletra is reserved for specific resistance or intolerance scenarios (ASHM HIV Guidelines, 2024).
• COVID-19: Large-scale studies, including the UK RECOVERY trial (Lancet, 2022), confirmed no significant benefit of Kaletra in COVID-19; not recommended for use in COVID-19 in Australia (see TGA advice).
• Pediatrics: Kaletra remains an important alternative for paediatric HIV, particularly where resistance or intolerance to first-line ART exists (Paediatric Infectious Diseases Journal, 2023).
• Pregnancy: Still considered a safe option in pregnancy, especially where other regimens are contraindicated (Australian Prescriber, 2023).

Availability and Delivery

Major pharmacy chains and specialist HIV services can arrange discreet postal delivery Australia-wide. Cold chain is not required if stored below 25°C.

Frequently Asked Questions (FAQ)

• Q1: Can I stop taking Kaletra if I feel well?
  A: No. You must not stop or miss doses without speaking to your doctor. Stopping suddenly can allow the virus to multiply and develop resistance.
• Q2: What should I do if I miss a dose?
  A: If less than 6 hours have passed, take your dose as soon as possible. If more than 6 hours, skip and take the next dose at the usual time. Never double the next dose.
• Q3: Can Kaletra be used during pregnancy?
  A: Yes, Kaletra is safe for use in pregnancy and is commonly recommended. Always inform your doctor if you are, or plan to become, pregnant for optimal therapy planning.
• Q4: Are generic versions available?
  A: As of 2024, some generic brands may be available through pharmacies and hospitals, depending on PBS listing and supply chains.
• Q5: Can I drink alcohol?
  A: Small amounts are unlikely to cause harm if you are taking tablets. Those on the oral solution should avoid alcohol-containing products. Always discuss alcohol use with your pharmacy team or doctor.

This information is not a substitute for medical advice. Please consult your HIV specialist, pharmacist, or clinic nurse for personal advice and support tailored to your circumstances.